This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Deciphera Pharmaceuticals, LLC. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Ann Gelormini: Innovator in CSF-1R Inhibitors
Introduction
Ann Gelormini is a prominent inventor based in Waltham, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of CSF-1R inhibitors. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Ann's latest patents include innovative processes for making CSF-1R inhibitors and methods of use thereof. The first patent focuses on processes of making a compound represented by Formula (I) and methods of use thereof. The second patent provides a compound of Formula (I) or a hydrate thereof, essentially free of one or more impurities, along with compositions thereof and methods of use.
Career Highlights
Ann Gelormini is currently employed at Deciphera Pharmaceuticals, LLC, where she continues to push the boundaries of pharmaceutical research. Her expertise in the field has made her a valuable asset to her team and the company.
Collaborations
Throughout her career, Ann has collaborated with notable colleagues, including Elena Kostik and Michael D Kaufman. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Ann Gelormini's work in the development of CSF-1R inhibitors showcases her innovative spirit and dedication to improving medical treatments. Her contributions are significant in the pharmaceutical industry, and her patents reflect her commitment to advancing science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile